Physician profile
Meera Reddy Wright
NPI 1548604044
$915.98
in general payments reported to CMS, 2019-2025
15 companies · $78.66 in 2025
The $78.66 reported for 2025 was less than what a typical Internal Medicine provider received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $143 · 2020: $164 · 2021: $151 · 2023: $14.54 · 2024: $366 · 2025: $78.66.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $459.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $458.78 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $155.66 | 2024 | Interstim |
| Astrazeneca Pharmaceuticals LP | $125.00 | 2020 | |
| Gilead Sciences, INC. | $124.73 | 2019 | |
| Takeda Pharmaceuticals U.S.A., INC. | $111.94 | 2024 | Gattex |
| Bayer Healthcare Pharmaceuticals INC. | $78.66 | 2025 | |
| Pfizer INC. | $75.79 | 2020-2021 | |
| Novo Nordisk INC | $50.00 | 2024 | Wegovy |
| Mylan Specialty L.P. | $47.98 | 2024 | Yupelri |
| E.R. Squibb & Sons, L.L.C. | $35.67 | 2021 | |
| Janssen Pharmaceuticals, INC | $29.49 | 2020-2021 | |
| Glaxosmithkline, LLC. | $18.64 | 2021 | |
| Alkermes, INC. | $17.96 | 2019 | |
| Abbvie INC. | $16.63 | 2021 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $14.54 | 2023 | Xifaxan |
| Merck Sharp & Dohme LLC | $13.29 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Meera Wright listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.